Development of Novel Compounds and Methods for Treatment of PARPs Mediated Disease

Xin Zhou; Steven H. Liang

doi:10.1021/acsmedchemlett.5c00530

September 25, 2025ACS Medicinal Chemistry LettersOpen Access

Development of Novel Compounds and Methods for Treatment of PARPs Mediated Disease

View Full Paper

Ask AI

Bookmark

Share

Key Points

Newly developed compounds show promise as therapeutic agents targeting PARPs in oncology, pointing to effective treatments.
The patent highlights poly(ADP-ribose) polymerases as crucial therapeutic targets, which could impact multiple diseases.
Innovative methods for treatment reveal a significant potential in managing PARP-related diseases, emphasizing the need for further research.
Therapeutic agents based on PARPs may revolutionize treatment approaches in oncology, opening doors for more effective interventions.

Implication

This patent reveals new compounds for treating PARP-related diseases, suggesting their role as therapeutic targets.

Abstract

Poly(ADP-ribose) polymerases (PARPs) are enzymes that primarily catalyze poly(ADP-ribosyl)ation and have emerged as important therapeutic targets in multiple diseases, particularly in oncology. This patent discloses novel compounds and methods for the treatment of PARP-related diseases, which highlightis their potential as promising therapeutic agents.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/68d7b3d4eebfec0fc5236585 https://doi.org/10.1021/acsmedchemlett.5c00530

View Full Paper

Ask AI

Bookmark

Share

Development of Novel Compounds and Methods for Treatment of PARPs Mediated Disease

Key Points

Implication

Abstract

Discussion

Cite This Study

Development of Novel Compounds and Methods for Treatment of PARPs Mediated Disease

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading